7th Pharmaron Symposium on Synthetic and Medicinal Chemistry
September 16, 2017 l Beijing Headquarters
- Dr. Markus Follmann, VP, Medicinal Chemistry, Bayer AG, Germany: Discovery of the Soluble Guanylate Cyclase Stimulators Riociguat and Vericiguat
- Dr. Andras Horvath, Scientific Director, Johnson & Johnson, Belgium : Development of Simeprevir (TMC435): A Study Case Macrocyclisation on Industrial Scale
- Prof. Jinbo Hu, Shanghai Institute of Organic Chemistry (SIOC), China: Developing New Fluorination and Fluoroalkylation Reagents by Tackling the Unique “Fluorine Effects”
- Dr. Garry Pairaudeau, Head of Hit Discovery, AstraZeneca, UK: Innovation in Lead Generation at AstraZeneca
- Prof. Sarah Reisman, Department of Chemistry, California Institute of Technology, USA : Necessity is the Mother of Invention: Natural Products and the Chemistry they Inspire
- Prof. Barry Trost, Stanford University, USA: Cycloadditions via TMM-Pd Intermediates: New Strategies for Asymmetric Induction and Total Synthesis
- Dr. Petr Vachal, AVP, Discovery Chemistry, Global Head of Screening, Target and Compound Profiling, MSD, USA: Merck (MSD) Drug Discovery Enabled
- Dr. Steven Wittenberger, Distinguished Research Fellow and Senior Director, Process R&D, AbbVie, USA: Process Research and Development for Venetoclax